A 40-year-old woman with diabetes contemplating pregnancy after gastric bypass surgery

JAMA

Volumn 299, Issue 21, 2008, Pages 2550-2557

  Coustan, Donald R ^a,b  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONCEPTION; FEMALE; HUMAN; HYPERTENSION; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PRIORITY JOURNAL; STOMACH BYPASS; WEIGHT REDUCTION;

EID: 44649094575     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.17.jrr80003     Document Type: Article

References (66)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195-1200.
2. Centers for Disease Control and Prevention. Prevalence of diagnosed diabetes per 100 population, by age, United States, 1980-2005. http://www.cdc.gov/diabetes/statistics/prev/national/tablebyage.htm. Accessed May 15, 2008.
3. Coustan DR. Perinatal mortality and morbidity. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:205-210.
4. Galan HL, Battaglia FC. The biology of normal and abnormal fetal growth and development. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:159-167.
5. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Technical review: pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19(5):514-541.
6. Dunne F, Brydon P, Smith K, et al. Pregnancy outcome in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med. 2003;20(9):734-738.
7. American College of Obstetricians and Gynecologists. Pregestational diabetes mellitus. Obstet Gynecol. 2005;105(3):675-685. ACOG practice bulletin 60.
8. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM. 2001;94(8):435-444.
9. American Diabetes Association. Standards of medical care in diabetes 2008. Diabetes Care. 2007;31(suppl 1):S12-S54.
10. American Diabetes Association. Position statement on preconception care of women with diabetes. Diabetes Care. 2004;27(suppl 1):S76-S78.
11. American College of Obstetricians and Gynecologists Committee on Practice Bulletins. Neural tube defects. Obstet Gynecol. 2003;102(1):203-213. ACOG practice bulletin 44.
12. Cousins L, Kitzmiller J, Schneider J, et al. The California Diabetes and Pregnancy Program: implementation of a multicenter experience with diabetic pregnancies. J Perinatol. 1992;12(2):173-180.
13. Elixhauser A, Wechsler JM, Kitzmiller JL, et al. Cost-benefit analysis of pre-conception care for women with established diabetes mellitus. Diabetes Care. 1993;16(8):1146-1157.
14. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and macular edema Diabetes Care. 2003;26(9):2653-2664.
15. Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev. 2006;82(1):23-28.
16. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354(23):2443-2451.
17. American College of Obstetrician and Gynecologists. Chronic hypertension in pregnancy. Obstet Gynecol. 2001;98(1)(suppl):177-185. ACOG practice bulletin 29.
18. Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisiting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060-1079.
19. Jovanovic L. Diabetic retinopathy. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004: 371-382.
20. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350.
21. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323.
22. Bouldin MJ, Ross LA, Sumrall CD, et al. The effect of obesity surgery on obesity comorbidity. Am J Med Sci. 2006;331(4):183-193.
23. Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care. 2005;28(2):481-484.
24. Gurewitsch ED, Smith-Levitin M, Mack J. Pregnancy following gastric bypass surgery for morbid obesity. Obstet Gynecol. 1996;88(4 pt 2):658-661.
25. Kakarla N, Dailey C, Marino T, et al. Pregnancy after gastric bypass surgery and internal hernia formation. Obstet Gynecol. 2005;105(5 pt 2):1195-1198.
26. Ahmed AR, O'Malley W. Internal hernia with Roux loop obstruction during pregnancy after gastric bypass surgery. Obes Surg. 2006;16(9):1246-1248.
27. Moore KA, Ouyang DW, Whang EE. Maternal and fetal deaths after gastric bypass surgery for morbid obesity. N Engl J Med. 2004;351(7):721-722.
28. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol. 2003;102(4):857-868.
29. Langer O, Koslowski S, Brustman L. Abnormal growth patterns in diabetes in pregnancy: a longitudinal study. Isr J Med Sci. 1991;27(8-9):516-523.
30. Oh W. Neonatal outcome and care. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:451-460.
31. Pettitt DJ, Baird HR, Aleck KA, et al. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med. 1983;308(5):242-245.
32. Pettitt DJ, Aleck KA, Baird HR, et al. Congenital susceptibility to NIDDM: role of intrauterine environment. Diabetes. 1988;37(5):622-628.
33. Pettitt DJ, Bennett PH, Saad MF, Charles MA, Nelson RG, Knowler WC. Abnormal glucose tolerance during pregnancy in Pima Indian women: long-term effects on offspring. Diabetes. 1991;40(suppl 2):126-130.
34. Pedersen J. The Pregnant Diabetic and Her Newborn. 2nd ed. Baltimore, MD: Williams & Wilkins; 1977:211.
35. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477-2486.
36. Kitzmiller JL. Diabetic nephropathy. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:383-424.
37. Leguizamón GF, Reece EA. Diabetic neuropathy and coronary heart disease. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:425-423.
38. Catalano PM, Buchanan TA. Metabolic changes during normal and diabetic pregnancies. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:129-145.
39. Carpenter MW. Exercise in normal and diabetic pregnancies. In: Reece EA, Coustan DR, Gabbe SG, eds. Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:283-297.
40. Coustan DR. Pharmacologic management of gestational diabetes: overview Diabetes Care. 2007;30(suppl 2):S206-S208.
41. Chan LY, Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril. 2005;83(4):955-958.
42. Palomba S, Orio F Jr, Falbo A, Manguso FL. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as first-line treatment for ovulation induction in nonobese anovulatory women with PCOS. J Clin Endocrinol Metab. 2005;90(7):4068-4074.
43. Palomba S, Orio F Jr, Nardo LG, et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with PCOS: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab. 2004;89(10):4801-4809.
44. Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril. 2005;83(5):1575-1578.
45. Hague WM, Davoren PM, McIntyre D, Norris R, Xiaonian X, Charles B. Metformin crosses the placenta: a modulator for fetal insulin resistance? [Rapid Response]. BMJ. http://bmj.bmjjournals.com/cgi/eletters/327/7420/ 880#42294. Published December 4, 2003. Accessed May 16, 2005.
46. Elliott BD, Langer O, Schenker S, Johnson RF. Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol. 1991;165(4 pt 1):807-812.
47. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134-1138.
48. Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med. 2004;15(1):51-55.
49. Hebert MF, Naragharisetti SB, Ma X, et al. Are we guessing glyburide dosage in the treatment of gestational diabetes (GDM)? the pharmacological evidence for better clinical practice. Am J Obstet Gynecol. 2007;197(6)(suppl):S25.
50. 125 in insulin-dependent diabetic mothers. J Clin Endocrinol. 1975;40(1):139-142.
51. Menon RK, Cohen RM, Sperling MA, et al. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. N Engl J Med. 1990;323(5):309-315.
52. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22(9):1422-1427.
53. Boskovic R, Feig DS, Derewlany L, et al. Transfer of insulin lispro across the human placenta. Diabetes Care. 2003;26(5):1390-1394.
54. Jovanovic L, Howard C, Pettitt D, et al. Insulin aspart vs regular human insulin in basal/bolus therapy for patients with gestational diabetes mellitus: safety and efficacy. Diabetologia. 2005;48(suppl 1):A317-A318.
55. Mathiesen ER, Kinsley B, Amiel S, et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30(4):771-776.
56. Jovanovic L, Pettitt DJ. Treatment with insulin and its analogs in pregnancies complicated by diabetes. Diabetes Care. 2007;30(suppl 2):S220-S224.
57. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes requiring insulin therapy. N Engl J Med. 1995;333(19):1237-1241.
58. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes. 1979;28(4):292-293.
59. Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708- 1712.
60. American College of Obstetricians and Gynecologists. Ultrasonography in pregnancy. Obstet Gynecol. 2004;104(6):1449-1458. ACOG practice bulletin 58.
61. American College of Obstetricians and Gynecologists. Vaginal birth after previous cesarean delivery. Obstet Gynecol. 2004;104(1):203-212. ACOG practice bulletin 54.
62. Hale TW, Kristensen JH, Hackett LP, Kohan R, Ilett KF. Transfer of metformin into human milk. Diabetologia. 2002;45(11):1509-1514.
63. Briggs GG, Ambrose PJ, Nageote MP, et al. Excretion of metformin into breast milk and the effect on nursing infants. Obstet Gynecol. 2005;105(6):1437-1441.
64. Feig DS, Briggs GG, Kraemer JM, et al. Transfer of glyburide and glipizide into breast milk. Diabetes Care. 2005;28(8):1851-1855.
65. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 7th ed. Philadelphia, PA: Lippincott; 2005:1020.
66. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13(1):34-40.